BioPharma Credit PLC

BOPCFOTCFinancial Services● Active

$0.91

+$0.91(+82064.72%)

Market Cap$1.0B

P/E Ratio—

52W High$1.02

52W Low$0.8364

Avg Volume383K

Open$0.94

Beta0.18

PE Ratio Market Cap Forecast

BioPharma Credit PLC (BOPCF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bopcf · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for BioPharma Credit PLC (BOPCF) measures how much investors pay for each dollar of the company's trailing earnings. BOPCF's current PE ratio of 8.35x is calculated by dividing its stock price of $0.91 by its TTM earnings per share of $0.12. −15.5% discount vs 5Y avg 9.9x

8.35x

P/E Ratio (TTM)−15.5%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E

N/A

—

EPS (TTM)

$0.12

TTM · diluted EPS

PEG Ratio

0.81

Below 1.0 · Growth adjusted

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioPharma Credit PLC SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2017 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 9.9x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 9 fiscal years · Front-end computed

Average

13.6x

9-yr mean

Median

11.5x

9-yr midpoint

Minimum

6.8x

Lowest year

Maximum

31.9x

Highest year

8.3x ← Now

6.8x
MinQ1 · 25%11.5x
MedianQ3 · 75%31.9x
Max

Within Historical Range

At 8.35x, BOPCF's current P/E is within its average historical range over the past 9 fiscal years.

33th percentileHigher than 3 of 9 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Asset Management · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
BioPharma Credit PLCYou BOPCF	$1.0B	8.35x	-68.6%	$0.12
Bolsa Mexicana de Valores, S.A.B. de C.V. BOMXF	$1.2B	12.21x	-54.0%	$3.10
Centuria Capital Group CNECF	$996M	15.69x	-40.9%	$0.10
Guardian Capital Group Limited GCAAF	$1.2B	9.45x	-64.4%	$4.30
IntegraFin Holdings plc IHPGF	$909M	13.17x	-50.4%	$0.16
Insignia Financial Ltd. IOOFF	$872M	82.30x	+209.8%	$0.02
Leonteq AG LNTQF	$889M	N/A	—	-$1.52
Industry Average 5 peers with valid PE	—	26.56x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-12-31Latest FY2025	7.46x	$0.11	-8.3%
2024-12-31 FY2024	8.13x	$0.10	-29.1%
2023-12-31 FY2023	11.47x	$0.08	+68.5%
2022-12-31 FY2022	6.81x	$0.13	-56.1%
2021-12-31 FY2021	15.52x	$0.06	+2.8%
2020-12-31 FY2020	15.11x	$0.06	+31.9%
2019-12-31 FY2019	11.46x	$0.09	-18.8%
2018-12-31 FY2018	14.10x	$0.07	-55.8%
2017-12-31 FY2017	31.91x	$0.04	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $0.91 ÷ $0.12 = 8.35x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

BOPCF pe ratio · 6 questions

BOPCF's current PE ratio is 8.35x as of 2026-06-08, based on a stock price of $0.91 and TTM EPS of $0.12. Data sourced from Financial Modeling Prep via BOPCF's SEC 10-K and 10-Q filings.

BOPCF PE ratioWhat is BOPCF PE ratioCurrent PE ratio of BOPCFBOPCF PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioPharma Credit PLC SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08